MedPath

Efficiency of bolus insulin therapy versus continuos infusion intravenous insulin in the liver transplant

Not Applicable
Conditions
terminal liver disease
C06.552.308.500.177
Registration Number
RBR-9y5tbp
Lead Sponsor
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Patient in anesthesia recovery room due to liver transplant; both sex; between 18 and 70 years old; blood glucose at least 180 mg/dl

Exclusion Criteria

Patients with severe disfunction after liver transplant; blood glucose values under 150 mg/dl; death at first 48 hours; double transplant

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath